专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4772871A Delta sigma modulator circuit for an analog-to-digital converter 失效
标题翻译：用于模数转换器的ΔΣ调制器电路
公开(公告)号：US4772871A
公开(公告)日：1988-09-20
申请号：US46783
申请日：1987-05-07
申请人： Takao Suzuki , Yasuo Shoji , Yuichi Shiraki
发明人： Takao Suzuki , Yasuo Shoji , Yuichi Shiraki
IPC分类号： H03M3/04 , H03M3/02 , H03M1/00
CPC分类号： H03M3/42
摘要： In a delta-sigma modulator for an A/D converter for modulating an analog input signal to produce a modulated signal of a digital form, a first integrator produces a first integral signal indicative of an integral of the difference between the analog input signal and feedback signal, a first delay element delays the first integral signal by one sampling period, a second integrator produces a second integral signal indicative of an integral of the difference between the output of the first delay element and the feedback signal, a first quantizer produces a two-level signal "1" or "0" depending on whether or not the second integral signal is greater than a predetermined reference, and a second quantizer produces a two-level signal "1" or "0" depending on whether or not the first integral signal is greater than a predetermined reference. An output digital signal is produced in accordance with the outputs of the first and the second quantizers. The feedback signal is also produced in accordance with the outputs of the first and the second quantizers.
摘要翻译：在用于调制模拟输入信号以产生数字形式的调制信号的A / D转换器的Δ-Σ调制器中，第一积分器产生指示模拟输入信号和反馈之间的差的积分的第一积分信号信号，第一延迟元件将第一积分信号延迟一个采样周期，第二积分器产生指示第一延迟元件的输出与反馈信号之间的差的积分的第二积分信号，第一量化器产生二 - 根据第二积分信号是否大于预定参考值，第二量化器根据第一和第二信号“1”或“0”是否产生两级信号“1”或“0” 积分信号大于预定参考值。根据第一和第二量化器的输出产生输出数字信号。还根据第一和第二量化器的输出产生反馈信号。

2. 发明授权

US4897832A Digital speech interpolation system and speech detector 失效
标题翻译：数字语音插值系统和语音检测器
公开(公告)号：US4897832A
公开(公告)日：1990-01-30
申请号：US297668
申请日：1989-01-17
申请人： Takao Suzuki , Yuichi Shiraki , Osamu Noguchi , Yasuo Shoji
发明人： Takao Suzuki , Yuichi Shiraki , Osamu Noguchi , Yasuo Shoji
IPC分类号： H04B3/23 , H04J3/17
CPC分类号： H04J3/175 , H04B3/23 , H04J3/172 , H04B3/234
摘要： A digital speech interpolation (DSI) system serves multiple PCM channels by multiplexing them to a single PCM signal, detecting the presence of speech on individual channels according to an adaptive power threshold, removing silent portions of the channel signals, and recombining them into a signal with fewer channels. A central echo canceler is provided between the DSI transmitter and the multiplexer, thus eliminating the need for a separate echo protection device at each terminal. The central echo canceler provides information to the speech detector enabling the speech dectector to avoid updating the adaptive power threshold when center clipping or double-talk occurs, thus preventing erratic speech detection performance. The speech detector also has a hangover controller that prevents speech dropouts by prolonging speech dectect intervals by an amount that is adjusted according to the length of the interval, and according to the current adaptive power threshold; this form of control enables a constant activity ratio to be maintained under varying noise levels. Benefits include improved communication quality and reduced system cost.
摘要翻译：数字语音插值（DSI）系统通过将多路复用到单个PCM信号来服务于多个PCM信道，根据自适应功率阈值检测单个信道上的语音的存在，消除信道信号的无声部分，并将其重新组合成信号渠道较少在DSI发射机和多路复用器之间提供中央回波消除器，从而消除了在每个终端处需要单独的回波保护装置。中央回波消除器向语音检测器提供信息，使得语音检测器能够在发生中心限幅或双向通话时避免更新自适应功率阈值，从而防止不规律的语音检测性能。语音检测器还具有宿醉控制器，其通过根据间隔的长度以及根据当前的自适应功率阈值延长语音检测间隔的量来防止语音丢失; 这种形式的控制使得能够在变化的噪声水平下保持恒定的活动比。优点包括提高通信质量和降低系统成本。

3. 发明授权

US5985882A Pyrazolo[1,5-a]pyrimidine derivatives 失效
标题翻译：吡唑并[1,5-a]嘧啶衍生物
公开(公告)号：US5985882A
公开(公告)日：1999-11-16
申请号：US930974
申请日：1997-10-10
申请人： Makoto Inoue , Takashi Okamura , Yasuo Shoji , Kinji Hashimoto , Masayuki Ohara , Tsuneo Yasuda
发明人： Makoto Inoue , Takashi Okamura , Yasuo Shoji , Kinji Hashimoto , Masayuki Ohara , Tsuneo Yasuda
IPC分类号： C07D487/04 , A61K31/505 , C07D487/00
CPC分类号： C07D487/04
摘要： The invention provides pyrazolo[1,5-a]pyrimidine derivatives which are useful as potent analgesics and represented by the formula ##STR1## wherein R.sup.1 is lower alkenyl, hydroxy(lower)alkyl, (lower)alkylthio(lower)alkyl, (lower)alkanoyloxy(lower)alkyl, (lower)alkoxy(lower)alkyl, furyl or thienyl, R.sup.2 is pyridyl, 1-oxide-pyridyl, lower alkyl-substituted pyrazinyl, lower alkyl-substituted pyrimidinyl, or phenyl which may have 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy and halogen, R.sup.3 is hydrogen or halogen, and A is a single bond or lower alkylene.
摘要翻译： PCT No.PCT / JP96 / 00955 Sec。 371日期：1997年10月10日 102（e）1997年10月10日PCT PCT 1996年4月5日PCT公布。公开号WO96 / 32394 日期：1996年10月17日本发明提供了吡唑并[1,5-a]嘧啶衍生物，其可用作强力止痛剂并由下式表示：其中R1为低级烯基，羟基（低级）烷基，（低级）烷硫基（低级）烷基，（低级）烷酰氧基（低级）烷基，（低级）烷氧基（低级）烷基，呋喃基或噻吩基，R2是吡啶基，1-氧化物 - 吡啶基，低级烷基取代的吡嗪基，低级烷基取代的嘧啶基或苯基，至3个选自低级烷基，低级烷氧基和卤素的取代基，R3为氢或卤素，A为单键或低级亚烷基。

4. 发明授权

US5081112A Method for treating hyperlipidemia 失效
标题翻译：治疗高脂血症的方法
公开(公告)号：US5081112A
公开(公告)日：1992-01-14
申请号：US375632
申请日：1989-07-05
申请人： Kazuhiko Tsutsumi , Tagui Sugimoto , Yoshihiko Tsuda , Eiji Uesaka , Kayoko Shinomiya , Yasuo Shoji , Atsushi Shima
发明人： Kazuhiko Tsutsumi , Tagui Sugimoto , Yoshihiko Tsuda , Eiji Uesaka , Kayoko Shinomiya , Yasuo Shoji , Atsushi Shima
IPC分类号： C12N9/99 , A61K31/66 , A61K31/675 , A61P3/06 , A61P43/00
CPC分类号： A61K31/675 , A61K31/66 , Y10S514/824
摘要： A pharmaceutical composition for treating hyperlipidemia containing, as the active ingredient, at least one carboxamide compounds represented by the formula (1) which possess excellent activities in lowering serum lipid, as well as having low toxicity with high safety.Said carboxamide compounds represented by the formula (1) are known compounds developed by the present inventors, but the pharmacological activities for treating hyperlipidemia have not been found yet.

5. 发明授权

US08305768B2 Secondary battery protecting module and lead mounting method 失效
标题翻译：二次电池保护模块和引线安装方法
公开(公告)号：US08305768B2
公开(公告)日：2012-11-06
申请号：US12252258
申请日：2008-10-15
申请人： Itaru Takeda , Tomoyuki Kato , Yasuo Shoji
发明人： Itaru Takeda , Tomoyuki Kato , Yasuo Shoji
IPC分类号： H05K7/00
CPC分类号： H05K3/3426 , H01M2/1022 , H01M10/052 , H05K2201/10818 , Y02P70/613 , Y10T29/49124 , Y10T29/49149
摘要： In a lead mounting method of mounting, onto a principal surface of a printed board, a lead to be connected to a terminal, a flat lead is prepared which lead has a mounted part to be disposed on the principal surface of the printed board and a connected part to be connected to the terminal. The flat lead is bent into an L shape so that the mounted part and the connected part are perpendicular to each other to obtain an L-shaped lead. The mounted part of the L-shaped lead is connected and fixed onto the principal surface of the printed board by soldering.
摘要翻译：在安装在印刷电路板的主表面上的引线安装方法中，要连接到端子的引线，准备一个引线，该引线具有要布置在印刷电路板的主表面上的安装部分，连接部分要连接到终端。扁平导线弯曲成L形，使得安装部分和连接部分彼此垂直以获得L形引线。 L形引线的安装部分通过焊接连接固定在印刷电路板的主表面上。

6. 发明授权

US06245779B1 Naphthyridine derivatives 失效
标题翻译：萘啶衍生物
公开(公告)号：US06245779B1
公开(公告)日：2001-06-12
申请号：US09445564
申请日：1999-12-09
申请人： Tadao Shibutani , Yasuo Shoji , Takashi Okamura , Tsuneo Yasuda , Takeshi Iwamoto
发明人： Tadao Shibutani , Yasuo Shoji , Takashi Okamura , Tsuneo Yasuda , Takeshi Iwamoto
IPC分类号： A61K314375
CPC分类号： C07D471/04
摘要： The present invention provides a naphthyridine derivative represented by the formula (1) wherein A is lower alkylene; R1 is H or an electron pair “-”; R2 is optionally substituted phenyl; when R1 is an electron pair “-”, R3 is a group represented by (wherein R4 and R5 each represent lower alkyl, etc.); when R1 is H, R3 is a group —S—R6 (wherein R6 is lower alkyl, etc.); and R7 is H or lower alkyl; and also provides an analgesic composition containing the above derivative as an active ingredient.
摘要翻译：本发明提供由式（1）表示的萘啶衍生物，其中A为低级亚烷基; R1是H或电子对“ - ”; R2是任选取代的苯基;当R 1是电子对“ - ”时，R 3是由（其中R 4和R 5各自表示低级烷基等）表示的基团; 当R 1为H时，R 3为基团-S-R 6（其中R 6为低级烷基等）; 并且R 7为H或低级烷基; 并且还提供含有上述衍生物作为活性成分的镇痛组合物。

7. 发明授权

US6166016A Amide derivatives 失效
标题翻译：酰胺衍生物
公开(公告)号：US6166016A
公开(公告)日：2000-12-26
申请号：US194727
申请日：1998-12-02
申请人： Takashi Okamura , Yasuo Shoji , Tadao Shibutani , Tsuneo Yasuda , Takeshi Iwamoto
发明人： Takashi Okamura , Yasuo Shoji , Tadao Shibutani , Tsuneo Yasuda , Takeshi Iwamoto
IPC分类号： C07D473/00 , A61K31/505 , C07D473/34 , C07D487/04 , C07D495/04 , C07C233/64 , A61K31/166 , A61K31/52
CPC分类号： C07D487/04 , C07D473/34 , C07D495/04
摘要： The invention provides amide derivatives which are useful as analgesics, anti-inflammatory agents, antimicrobial drugs, hypoglycemic agents, hypolipidemic agents, antihypertensive agents, anti-cancer agents, etc., the derivatives being represented by the formula ##STR1## wherein ring A represents a benzene ring, a naphthalene ring, a pyridine ring or a furan ring; R.sup.4 represents a heterocyclic group selected from the group consisting of a lower alkyl-substituted thieno[3,2-d]pyrimidin-4-yl group, an optionally substituted pyrazolo[1,5-a]-1,3,5-triazin-4-yl group, a pyrazolo[3,4-d]pyrimidin-4-yl group substituted at the 6-position and a purin-6-yl group substituted at the 2-position; and R.sup.5 represents a hydrogen atom or a group represented by ##STR2##
摘要翻译： PCT No.PCT / JP97 / 01875 Sec。 371日期1998年12月2日第 102（e）日期1998年12月2日PCT提交1997年6月2日PCT公布。公开号WO97 / 46560 PCT 日期1997年11月12日本发明提供可用作止痛剂，抗炎剂，抗微生物药物，降血糖药，降血脂药，降压药，抗癌剂等的酰胺衍生物，其衍生物由下式表示：其中环 A表示苯环，萘环，吡啶环或呋喃环; R 4表示选自低级烷基取代的噻吩并[3,2-d]嘧啶-4-基，任选取代的吡唑并[1,5-a] -1,3,5-三嗪 -4-基，在6位被取代的吡唑并[3,4-d]嘧啶-4-基和在2位被取代的嘌呤-6-基; 并且R 5表示氢原子或由其表示的基团

8. 发明授权

US5985858A Phosphonic diester derivatives 失效
标题翻译：膦酸二酯衍生物
公开(公告)号：US5985858A
公开(公告)日：1999-11-16
申请号：US91946
申请日：1998-06-26
申请人： Kazuyoshi Miyata , Yasuhiro Sakai , Yasuo Shoji , Yoshihiko Tsuda , Yasuhide Inoue , Keigo Sato , Shinya Miki
发明人： Kazuyoshi Miyata , Yasuhiro Sakai , Yasuo Shoji , Yoshihiko Tsuda , Yasuhide Inoue , Keigo Sato , Shinya Miki
IPC分类号： C07F9/6509 , C07F9/6539 , C07F9/6553 , C07F9/6558 , C07F9/6561 , A61K31/67 , A61K31/675
CPC分类号： C07F9/650964 , C07F9/6539 , C07F9/655345 , C07F9/65583 , C07F9/65586 , C07F9/6561
摘要： A phosphonic diester derivative represented by the following formula (1): ##STR1## wherein R.sup.1 represents a cycloalkyl group; a phenyl group which may have 1 to 3 substituents selected from the group consisting of a lower alkoxy group, a lower alkyl group, a halogen atom, a halogen-substituted lower alkyl group, a lower alkanoyl group, a nitro group, a benzoyl group, a cyano group, an N-lower alkylcarbamoyl group, an N-phenyl-lower alkylcarbamoyl group, an N-(halogen-substituted phenyl)carbamoyl group and an N,N-di-lower alkylcarbamoyl group; a 1,3,4-thiadiazol-2-yl group having a halogen-substituted lower alkyl group as a substituent; a thiazolyl group; a pyridyl group which may be substituted by a halogen atom; a benzothiazol-2-yl group having 1 to 2 lower alkoxy groups on the phenyl ring; or a 4,5-dihydrothieno[3,2-e]benzothiazol-2-yl group; R.sup.2 represents a hydrogen atom or a phenyl lower alkyl group; R.sup.3 and R.sup.4 each represents a lower alkyl group; and A represents a heterocyclic ring selected from the group consisting of a pyrazine ring, a thiophene ring and a phenyl-substituted thiazole ring; the derivative being of value as an agent for treating and preventing hyperlipidemia, diabetes and cataract, or as an antitumor agent.
摘要翻译： PCT No.PCT / JP96 / 03775第 371日期：1998年6月26日 102（e）日期1998年6月26日PCT 1996年12月24日PCT公布。公开号WO97 / 24360 PCT 日期：1997年7月10日由下式（1）表示的膦酸二酯衍生物：其中R1表示环烷基; 可以具有1〜3个选自低级烷氧基，低级烷基，卤素原子，卤素取代的低级烷基，低级烷酰基，硝基，苯甲酰基的取代基的苯基，氰基，N-低级烷基氨基甲酰基，N-苯基 - 低级烷基氨基甲酰基，N-（卤素取代的苯基）氨基甲酰基和N，N-二低级烷基氨基甲酰基; 具有卤素取代的低级烷基作为取代基的1,3,4-噻二唑-2-基; 噻唑基可被卤素原子取代的吡啶基; 在苯环上具有1至2个低级烷氧基的苯并噻唑-2-基; 或4,5-二氢噻吩并[3,2-e]苯并噻唑-2-基; R2表示氢原子或苯基低级烷基; R3和R4各自表示低级烷基; A表示选自吡嗪环，噻吩环和苯基取代的噻唑环的杂环; 该衍生物作为治疗和预防高脂血症，糖尿病和白内障或作为抗肿瘤剂的药剂是有价值的。

9. 发明授权

US5376665A Phosphonic diester derivatives 失效
标题翻译：膦酸二酯衍生物
公开(公告)号：US5376665A
公开(公告)日：1994-12-27
申请号：US182145
申请日：1994-01-14
申请人： Kazuyoshi Miyata , Yasuo Shoji , Yoshihiko Tsuda , Kazuhiko Tsutsumi , Yasuhide Inoue , Chieko Naba , Yasuhisa Kurogi
发明人： Kazuyoshi Miyata , Yasuo Shoji , Yoshihiko Tsuda , Kazuhiko Tsutsumi , Yasuhide Inoue , Chieko Naba , Yasuhisa Kurogi
IPC分类号： A61K31/675 , C07F9/6506 , C07F9/653 , C07F9/6541 , C07F9/6561 , C07D235/04 , A61K31/415 , A61K31/44 , C07D221/04
CPC分类号： C07F9/6561 , C07F9/65068 , C07F9/65324 , C07F9/6541
摘要： The invention provides a phosphonic diester derivative of the general formula ##STR1## The phosphonic diester derivative of the invention has hypoglycemic and hypolipidemic activities, for instance, and is of value as an antidiabetic or anti-hyperlipidemic agent.

10. 发明授权

US5707997A Pyrazolo�1,5-a!pyrimidine derivative 失效
标题翻译：吡唑并[1,5-a]嘧啶衍生物
公开(公告)号：US5707997A
公开(公告)日：1998-01-13
申请号：US602824
申请日：1996-02-21
申请人： Yasuo Shoji , Makoto Inoue , Takashi Okamura , Kinji Hashimoto , Masayuki Ohara , Tsuneo Yasuda
发明人： Yasuo Shoji , Makoto Inoue , Takashi Okamura , Kinji Hashimoto , Masayuki Ohara , Tsuneo Yasuda
IPC分类号： C07D487/04 , A61K31/505 , C07D403/02
CPC分类号： C07D487/04
摘要： The invention provides a pyrazolo�1,5-a!pyrimidine derivative of the following formula (1): ##STR1## wherein R.sup.1, R.sup.3, R.sup.4, R.sup.5, R.sup.6, Q, A and n are defined in the description; and R.sup.2 is naphthyl, cycloalkyl, furyl, thienyl, optionally halogen-substituted pyridyl, optionally halogen-substituted phenoxy, or phenyl which may have 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, halogen, nitro, halogen-substituted lower alkyl, halogen-substituted lower alkoxy, lower alkoxycarbonyl, hydroxyl, phenyl(lower)alkoxy, amino, cyano, lower alkanoyloxy, phenyl and di(lower)alkoxyphos-phoryl(lower)alkyl. This derivative is useful as a potent analgesic.
摘要翻译： PCT No.PCT / JP95 / 01104 Sec。 371日期1996年2月21日 102（e）日期1996年2月21日PCT提交1995年6月5日PCT公布。出版物WO95 / 35298 日期：1995年12月28日本发明提供下述通式（1）的吡唑并[1,5-a]嘧啶衍生物：d n在说明书中定义; R 2为萘基，环烷基，呋喃基，噻吩基，任选卤素取代的吡啶基，任选卤素取代的苯氧基，或可具有1至3个选自低级烷基，低级烷氧基，卤素，硝基，取代的低级烷基，卤素取代的低级烷氧基，低级烷氧基羰基，羟基，苯基（低级）烷氧基，氨基，氰基，低级烷酰氧基，苯基和二（低级）烷氧基磷酰基（低级）烷基。该衍生物作为有效的止痛剂是有用的。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式